company profile

Print
 
 
AstraZeneca is committed to helping reduce the global burden and complications of diabetes. With cardiovascular and metabolic disease (CVMD) as a core therapy area for the company, we aim to understand how cardiovascular disease, chronic kidney disease and diabetes interact and impact one another. Our objective is to develop better therapies to address multiple risk factors associated with CV morbidity, mortality and organ damage.
   

 

Bayer (China) Limited
Tel: +86 10 65893000
Fax: +86 10 65893243
Bayer Health care
No 33, Huayuan Shiqiao Road, Pudong 18-19/F, 23-26/F, Citigroup Tower, Shanghai 200120, China
Tel: +86 10 5921 8282
Fax: +86 10 5921 8181
Website:www.bayer.com.cn

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
A growing and aging world population requires an adequate supply of food and improved medical care. Our research and development activities are therefore focused on improving people’s quality of life by preventing, alleviating and treating diseases. At the same time, we are making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials. Our understanding of the biochemical processes in living organisms helps us address these demanding challenges.
We are committed to operating sustainably and addressing our social and ethical responsibilities. We also respect the interests of all our stakeholders. Employees with a passion for innovation enjoy excellent development opportunities at Bayer.

 

 



Eli Lilly China
F16, 21, 23, No.222, Hubin Rd, No.1 Qiye Avenue, Shanghai, China
Tel: +862123020000
Website:
www.lilly.com

Eli Lilly begins with a promise…
In 1876, Colonel Eli Lilly founded the company that bears his name to make trusted medicines of the highest possible quality, based on the best science of the day.
 In 2014, the people if Eli Lilly and company launched 3 new medicines to treat diabetes and cancer gained approval for 4th medicine that represent the ongoing fulfillment of the promise made more than 140 years ago by our founder.
Today, Eli Lilly and company continues to pursue the promise of innovation—guided by our core values of integrated, excellence, and respect for people—as we prepare to launch more new medicines to bring healing and hope to people around the world. On the cover: Monica Kumado works on a packaging line for Humalog vials in Lilly’s manufacturing operations in Indianapolis. Generations of Lilly manufacturing employees have sustained Lilly’s commitment to producing quality medicines.

 

 



MSD
Website:
www.msd.com,
www.msdchina.com.cn

About MSD
For 125 years, MSD has been a global health care leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Kenilworth, N.J., USA. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
About MSD in China
China is one of the most critical markets for MSD’s growth strategy. MSD China is powered by three engines: commercial operation headquartered in Shanghai, research and development in Beijing, and manufacturing in Hangzhou. We are committed to bringing quality innovative medicines, vaccines, and services to more Chinese people. For more information, visit www.msdchina.com.cn, or follow us on WeChat at msd_china.

 

 



Novo Nordisk (China) Pharmaceuticals Co., Ltd.
18F, East Tower
World Financial Center
No.1 East 3rd Ring Middle Road, Chaoyang District 100020 Beijing China
Tel:+86(10)5961 5858
Fax:+86(10)6505 6668
Website:
www.novonordisk.com.cn

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 41,500 employees in 75 countries, and markets its products in more than 180 countries. Novo Nordisk’s B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com.cn, Facebook, Twitter, LinkedIn, YouTube

 

 



Tianjin takeda pharmaceuticals co., LTD
29F, No. 1717 West Nanjing road Wheelock Square, Jingan District, Shanghai
Tel: +86 21 22306888
Website:
www.takeda.com.cn

Takeda is the largest Pharma company in Asia and is ranked number 12 globally. Based on the corporate philosophy of "Takeda-ism" (Integrity: Fairness, Honesty and Perseverance) developed over its long corporate history of more than 230 years, Takeda conducts activities according to the corporate mission to “strive towards better health for people worldwide through leading innovation in medicine.”


 

  通化东宝药业股份有限公司
 上海淮海中路918号,久事复兴大厦19F1   200020
Website:www.dongbao.com.cn

Founded in 1985, Tonghua Dongbao Pharmaceutical Ltd. is a conglomerate industrial group, actively engaged in the field of pharmaceutical production and is now one of the pioneering manufacturers of recombinant biopharmaceuticals, especially recombinant human insulin.
Through research and innovation, we take an active part in pharmaceutical and biotech development to make valuable contribution to the world community.
In Dongbao, innovative R&D programs, state-of-art technology facilities, rigorous quality control systems, effectual marketing strategies as well as satisfactory after-sales services have been integrated into a well organized business operation system.
Since its establishment, Dongbao Group has demonstrated its commitment to improving people's life and adding good value to the society. Due to its achievements, Dongbao is enjoying a sound international recognition today and will endeavor to further its international collaboration.

 

 



Sanofi(China)
19F Tower III, Kerry Center 1228 Middle Yan’an Road, Jing An District, Shanghai 200040
Tel: +86021-22266666

SANOFI, A GLOBAL LIFE SCIENCES COMPANY
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

 

 

Global Medicines Development
1 MedImmune Way, Gaithersburg, MD 20878
Website: 
www.astrazeneca.com
 AstraZeneca is committed to helping reduce the global burden and complications of diabetes. With cardiovascular and metabolic disease (CVMD) as a core therapy area for the company, we aim to understand how cardiovascular disease, chronic kidney disease and diabetes interact and impact one another. Our objective is to develop better therapies to address multiple risk factors associated with CV morbidity, mortality and organ damage.
   



Shenyang Corporate Headquarters and Manufacturing Facilities
No.3 A1, Road 10
Shenyang Economy & Technology Development Zone
 Shenyang, China 110027
Tel: +86 24 2538 6000
Fax: +86 24 2581 1821
Website:
www.3sbio.com

3Ssbio - A Pioneer and Undisputed Market Leader in the PRC          Biotechnology Industry

  • A pre-eminent player with 7 approved biological products in China’s fast growing biopharmaceutical industry 
  • Robust product pipeline – 28 candidates, among which 16 are being developed as National Class I drugs 
  • Augmented pipeline with monoclonal antibody (“mAb”) product candidates through acquisition of Guojian, including total 10 biological products (6 Class I drugs) 
  • State-of-the-art manufacturing facilities
    -11 antibody production lines with over 38,000 liter capacity
    -Small molecule production plant, mammalian cell based production plant, and bacterial cell based production plant 
  • Leading commercial platform with around 2,000 sales and marketing employee focusing on oncology, rheumatology, nephrology, metabolic and dermatology  
  • strong emphasis on academic marketing, covering over 6,000 hospitals and medical institutions, including over 2,000 Grade III hospitals(excluding hospitals covered by Byetta sales team)

 

 

 

Merck Serono Co.,Ltd
25F, NUO Center office,No.A2,jiangtai Road, Chaoyang District, Beijing
Tel: 010-59072462
Email: Wei.jiang@merckgroup.com
Website: www.merckgroup.com

 

Merck Healthcare China With nearly 2000 employees and business presence throughout the country, Merck Healthcare is committed to serving China and markets 17 medicines in 7 major therapeutic areas and a TSH point-of-care diagnosis equipment for hypothyroidism screening in China at present. Merck Healthcare China is No. 1 in fertility and thyroid therapeutic areas, and has strong presence in CV, endocrinology and oncology. The R&D Beijing Hub, established in November 2009, is an integrated R&D facility, aimed at stimulating innovation, introducing new medicines to China even Asia paralleling market timelines in the West, and leading research and development into new treatment solutions for critical diseases in Asia. Merck’s main therapeutic areas include fertility, oncology, cardiovascular, surgery and emergency, thyroid disease, diabetes, allergy. Product brands include Gonal-f® to treat infertility, the assistive reproduction products Ovidrel® , Luveris® , Cetrotide® , and Crinone® ; oncology product Erbitux® , Xalkori® for non-small  cell lung cancer, co-promoted by Merck-Pfizer Alliance; Concor®for high blood pressure, Sigmart® for angina pectoris, Stilamin® for acute gastrointestinal diseases, Euthyrox® for hypothyroidism and Thyrozol® for hyperthyroidism, Glucophage®, Glucophage XR® Glufast® for diabetes and Doxium® for diabetic ophthalmic complication, and NHD for allergies.

 

 

 

6 Floor, West Building ,World Financial Center,No.1, East 3rd Ring Middle Road, Chaoyang District ,100020 Beijing China
Telephone: 86 010 65610341
Fax: 86 010 65610348
Website: www.servier.com.cn

Servier is the leading French independent pharmaceutical company, present in 148 countries with 21 200 employees and a turnover of 4 billion euros in 2016.
25% of Servier’s annual turnover is reinvested in Research & Development, reflecting the company’s dedication to its research mission of innovation and discovery to treat unmet medical needs.
Organized as a foundation, we guaranty our independence toward stock exchange market. As our founder Doctor Jacques Servier used to say: “a company is a group of human being, so it has no price”.
44 new chemical entities currently under development in the following therapeutic fields: cardiovascular diseases, diabetes and psychiatry, cancer research, central nervous system and metabolism, and rheumatology.

 


Abbott Laboratories Trading (Shanghai) Co., Ltd.
31/F Ciro’s Plaza,288 West Nan Jing Road, Shanghai 200003, P.R. China
Tel: +86 21 23204185
Fax:+86 21 63346300
Email: yang.liu1@abbott.com,
Website:
www.abbott.com.cn

At Abbott, we’re all about helping you live the best life you can through good health. We keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines and breakthroughs to manage your health. Every day and around the world, we’re discovering new ways to make life better.

 

 

 

CR Double Crane
Suite 315, No.12 Ziming Mansion, Xinzhong street, Dongcheng District, Beijing, China, 100027
Tel: 010-64159689
Email: wangyuanyuan@dcpc.com,
Website:
www.dcpc.com

CR Double-Crane Pharmaceuticals Co., Ltd is a pharmaceuticals company with 77 years of brilliant history. Sticking to the company mission of “caring for people and their health”, CR Double-Crane is always making great effort and keeping its faith. Today, the company has become a large-size listed pharmaceuticals group company with over ten subsidiaries and more than 12,000 staff. It focuses on sectors such as infusion, cardiovascular and cerebrovascular, endocrine, and pediatric medicines and has many famous products such as Compound Reserpine and Triamterene Tablets (No.O), Gliquidone Tablets , Hydroxyethyl Starch(200/0.5)and Sodium Chloride Injection (Ying Yuan).

 

 


Medtronic plc
Block 11,No.3000 Long Dong Avenue,Pudong,Shanghai
201203,P.R.China(上海市浦东新区龙东大道3000号11号楼5层)
Tel: (+86-21)20325987
Fax: (+86-21)50801850
Email: ning.zhou@medtronic.com
Website:
www.medtronicdiabetes.com.cn

As a global leader in medical technology, services and solutions, Medtronic improves the lives and health of millions of people each year. We use our deep clinical, therapeutic, and economic expertise to address the complex challenges faced by healthcare systems today. Let’s take healthcare Further, Together. Learn more at Medtronic.com.

 

 




Novartis Pharmaceuticals (China)
2F, Building 1,
No. 4218 Jingke RoadZhangjiang Hi-Tech Park, PudongShanghai, 201203, China
Tel: 021-61606000
Fax: 02161603162
Website: www.novartis.com.cn

Novartis are inspired by patients every day.
This inspiration motivates us to revolutionize the research, development and manufacturing of quality innovative medicines that help people live longer with a better quality of life giving them more time to do the things that matter to them.
To do our best for patients we do not accept the status quo. We work to enable patient access worldwide so that patients and society can benefit as quickly as possible.
The depth and strength of our pipeline enables us to change the practice of medicine, and to bring more breakthroughs with real benefits to patients and society.
We partner with people and organizations around the world because by working together we can make a greater difference.
We continually challenge ourselves to the highest standards of compliance, integrity and performance in all that we do to ensure a sustainable future of innovation for patients, society and Novartis.

   
 

38/F, CITIC square, 1168 Nanjing Road(W) Shanghai 200041
Tel: (021) 60432500
Fax: (021) 52925885
Web
www.pfizer.com.cn

 

Founded in 1849, Pfizer is the world’s largest research – based bio-pharmaceutical company.

We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people.

For more than 160 years, Pfizer has been working to make a difference for all who rely on us.

Our objective is to innovate to bring therapies to patients that significantly improve their lives; and Our Mission is to be the premier innovative biopharmaceutical company.

 



HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO.,LTD.
No.866,Moganshan Road,Hangzhou
Tel: 0571-89903388
Fax:0571-89903366
Email: scb05@eastchinapharm.com 
Website:
www.eastchinapharm.com

HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL locates near the beautiful West Lake. The company was founded in 1992, December 31. It is a comprehensive pharmaceutical enterprise that focus on medicine, western medicine, biological technology product and its preparations. Company's existing staff of nearly 3500 people, including 900 technicians , accounting for nearly 25% of the total employees, which is a high and new tech enterprise.

 

 


Beijing Tide Pharmaceutical Co., Ltd
No.8 East Rongjing Street,
 Beijing Econnomic-technological Development Area(BDA),
 Beijing, P.R.China
Tel:(010)67889939
Fax:0571-89903366
Email: IR@tidepharm.com 
Website:
www.tidepharm.com, en.tidepharm.com

Beijing Tide Pharmaceutical Co., Ltd is a Sino-foreign joint venture that established in May 1995 and located at the core of Beijing Economic-Technological Development Area (DBA). Tide is the first high-tech pharmaceutical enterprise in China with the capability of developing, manufacturing as well as marketing series of targeted drugs. Through adhering to the principle of “Care for Life and Keep Innovating” and taking independent innovation, independent development as well as introducing, absorbing and re-innovating as development direction, Tide strives to develop new drugs with proprietary intellectual property rights. Based on keeping a foothold inland and opening eyes to the whole world, it will make unremitting endeavor to provide novel drug products with higher quality and improve public health level.

 



Johnson & Johnson Diabetes Care Companies
18F Building A, Xinyan Mansion, No. 65, Guiqing Rd., Xuhui District, Shanghai 200233, China
Tel: 800 820 1800/400 820 1800
Fax: +86 21 3337 7386
Email: bsun16@its.jnj.com 
Website:
www.jjmc.com.cn

Johnson & Johnson Diabetes Care Companies provide total solutions to customers for In-hospital Patients Glucose Management (IPGM) in China. These solutions include not only the Blood Glucose Monitoring System (Statstrip® BGMS, cleared by FDA for use for all types of patients including the critical ill), but also the diabetes management system (DMS), the diabetic management quality evaluation model, and the online training platform (LMS) which is sponsored by JJDI. The company enjoys established reputation for diabetic care and education in China for over 20 years, and serves over millions of patients and HCPs every year.

 

 



Shanghai MicroPort Lifesciences Co., Ltd
Building#24,588 Tianxiong Rd.SIMZ Bio Business Park Shanghai 201318, P.R.China
Tel: 021-38954600-3750
Fax:0571-89903366
Email: zhengj@microport.com
 

Shanghai MicroPort Lifesciences Co., Ltd. was founded in the Shanghai International Medical Zone on April 28, 2008. It is a wholly owned subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd. and its primary focus is on the development, manufacture, monitoring and management of medical devices for the treatment of diabetes and disorders of sexual development.